You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 16, September 12, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Immunization
 •Viral Infections
 •Alert me on articles by topic

Influenza Vaccination Effectiveness Is Not Proven in Younger Individuals at Risk

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hak and colleagues1 have performed a good case-control study, and the results are greatly in favor of influenza vaccination for persons at risk. However, their conclusion that influenza vaccination is also beneficial for persons at risk younger than 18 years is not convincing. The authors show a reduction of general practice visits among this age group, but these findings could not be confirmed in some recent randomized controlled trials.2-3 It is surprising that the authors only refer to older studies that have serious flaws, as reported before by one of us.4 Hak et al1 do not refer to the recent randomized controlled trial by Hoberman et al2 in which no effect was found of influenza vaccination on acute otitis media or utilization of selected health care and related resources.

Certainly, because this is a case-control study, Hak and colleagues1 should be reluctant in advising to vaccinate this younger group as . . . [Full Text of this Article]


AUTHOR INFORMATION
Roger Damoiseaux, PhD; Johannes C. van der Wouden, PhD; Herman Bueving, PhD


RELATED LETTER

Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical Conditions: The PRISMA Study
Eelko Hak, Erik Buskens, Gerrit A. van Essen, Dinny H. de Bakker, Diederick E. Grobbee, Margot A. J. B. Tacken, Ben A. van Hout, and Theo J. M. Verheij
Arch Intern Med. 2005;165(3):274-280.
ABSTRACT | FULL TEXT  

RELATED ARTICLES

Influenza Vaccination Effectiveness Is Not Proven in Younger Individuals at Risk—Reply
Eelko Hak, Erik Buskens, and Theo J. M. Verheij
Arch Intern Med. 2005;165(16):1922.
EXTRACT | FULL TEXT  

Clinical Effectiveness of Influenza Vaccination in Persons Younger Than 65 Years With High-Risk Medical Conditions: The PRISMA Study
Eelko Hak, Erik Buskens, Gerrit A. van Essen, Dinny H. de Bakker, Diederick E. Grobbee, Margot A. J. B. Tacken, Ben A. van Hout, and Theo J. M. Verheij
Arch Intern Med. 2005;165(3):274-280.
ABSTRACT | FULL TEXT  

Effectiveness of Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Young Children: A Randomized Controlled Trial
Alejandro Hoberman, David P. Greenberg, Jack L. Paradise, Howard E. Rockette, Judith R. Lave, Diana H. Kearney, D. Kathleen Colborn, Marcia Kurs-Lasky, Mary Ann Haralam, Carol J. Byers, Lisa M. Zoffel, Irene A. Fabian, Beverly S. Bernard, and Jill D. Kerr
JAMA. 2003;290(12):1608-1616.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.